Early studies demonstrated its ability to promote angiogenesis, reduce inflammation, and enhance wound healing in animal studies
Methods: This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC)
Safety Considerations and UK Regulatory Status Retatrutide is not MHRA-approved, meaning self-use outside clinical trials carries risks including product impurity, incorrect dosing, gastrointestinal adverse effects, and no pharmacovigilance oversight
P to GSL : Appropriate when the medicine can be sold with reasonable safety outside of a pharmacy environment, meaning the hazard to health, risk of misuse, or need for special precautions is small, and wider sale is a convenience
And let's build a pathway that makes sense, that maybe is a more nuanced approach to driving healthspan